ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TILS Tiziana Life Sciences Plc

58.50
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tiziana Life Sciences Plc LSE:TILS London Ordinary Share GB00BKWNZY55 ORD 3P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 58.50 45.00 60.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Tiziana Life Sciences Share Discussion Threads

Showing 12926 to 12949 of 17925 messages
Chat Pages: Latest  525  524  523  522  521  520  519  518  517  516  515  514  Older
DateSubjectAuthorDiscuss
26/1/2021
15:30
About time
markstevenkirby80
26/1/2021
15:28
Americans seem to like it fran, outlining our pipeline that could produce $$$$$$$$Big bucks soon...........
mark0419
26/1/2021
15:23
Some confident people on twitter today that we'll see that big RNS.
mark0419
26/1/2021
15:22
Good old US of A pulling us up before possibly the big game changer RNS. Immenant.
mark0419
26/1/2021
15:21
Up 12% stateside and rising!
jpuff
26/1/2021
15:14
Sure is but the UK is lagging, could it be to align the listings as there is still continued disparity between listings...
rebelwithacause1
26/1/2021
15:12
I'm not sure Fan because it's been disclosed in the past, maybe its a concise version for the 'Ignorant' masses.

However, funding is confirmed until the end of 2022, not an enormous amount of time, especially within the 'Trials and Tribulations' of BioPharma...And there doesn't seem to be any contigency which is worrying if it doesn't go to plan when other prominent trials may not even come to fruition with a lack of funding from their 'Significant Pipeline'...but there's always the potential of an RI...

rebelwithacause1
26/1/2021
15:07
U.S likes it , up9% at the mo
heliman2
26/1/2021
14:57
What was the relevance of today’s RNS?
fandagle
26/1/2021
14:28
See my dear friend Walkmi, a 'Common' investor like yourself filters when investing is becoming rather sentimental, if you get my drift...just don't lose your 'Shirt' hey!

...AbbNat, such history we have but if its any consolation, I have no plans to leave my humble abode here - hehe!

...And there goes the 'Fool with his ohh so little Tool' Mark0419, posted from a confident poster on the LSE, I do wonder whether thats you - oops!

...By the way Yid, so do you see by your comment as to why the masses will not realise the 'Potential' here...And I wasn't aware any traction whatsoever with licensing had been achieved especially when 'Proof of Concept' hasn't even been validated yet through the obligatory 'Peer Reviews' - such expertise you have within Biopharma but stretches the truth somewhat!

rebelwithacause1
26/1/2021
14:10
Well the 'Champ' is back! Had a few other things to contend with this mornining so my sincere apologies for the delay - hehe!

A few facts though...

Firstly, Dr Neil Graham did not leave Regeneron for Tiziana - I think you'll find he was at the transition of retiring not transferring from one company to the other folks!

Secondly but most importantly investors are selling not due to impatience but not realising their investments on the 'Efficacy of trials' which have considerable risk, especially where human lives are involved...And if it was so assured by KSs 'Fireside chat, why is it languishing...

Lastly but just as important - loving the comedy my dear friend Fan!

rebelwithacause1
26/1/2021
13:02
At this rate we will be returning back to Aim as we slide down the ftse :)
twodegrees
26/1/2021
11:52
The development path smaller Biotechs usually follow is to get their assets part or fully through Phase 2, by which point big pharma take much more of an interest. It is at that point that licensing deals tend to take place in the form of upfront payments, milestone payments covering the final development (phase 3, NDA etc) and licensing deals. The alternative which Celgene, Tesaro and many others have followed is they get acquired in their entirety.
yidarmytom
26/1/2021
11:00
Millionaires will be buying at 50p.
small crow
26/1/2021
10:48
We are cashed up, transformational data due in next few days, great bod with a fantastic new addition to the team recently. Great pipeline. Sounds pretty compelling reason to invest for me. The reason for the sell off is the same reason why 70% of peopleLose money on the markets.. no patience to hold for more then 5 mins. Panic at first sign of red. If it was easy we would all be millionaires. 
mark0419
26/1/2021
09:46
Not looking good in Brazil for Covid-19 patients running out of oxygen cylinders now..........https://news.sky.com/story/covid-19-brazil-crisis-like-medieval-plague-as-patients-suffocate-without-oxygen-12198178
mark0419
26/1/2021
09:30
Copied from a confident poster off LSE.................................................................... I believe the next rns this week will be all about covid to have the maximum effect !!This bod is top notch in every way and new appointment has moved from £50 billion Regeneron to little old Tils ........ you would only do that if you strongly believed that they had something worthy in the pipeline.This year is going to be phenomenal and the proper re-rate starts this week in my opinion.
mark0419
26/1/2021
09:26
https://ir.tizianalifesciences.com/presentation
mark0419
26/1/2021
09:14
Shame how we never see you add to the story here?
mark0419
26/1/2021
09:13
With the last dosed person of the Covid-19 treatment being last week of December. Will we get the results this week. In the fireside chat he mentioned a few weeks surely it must be imminent. Next extended trial needs to be started ASAP.
mark0419
26/1/2021
07:55
Walki sorry you feel that way, would like nothing better than to log on and Reb has disappeared. I will ignore him from now on, as yes, it only perpetuates his drivel.
impala391
26/1/2021
07:37
if we get this then we will be rapidly moving to a large expansion of the trial

Primary endpoints:

Safety and tolerability
Nasal tolerance

Secondary endpoints:

Reduction in use of ventilators, Disease symptoms, PRO TNSS questionnaire, Smell
sensation and appetite

Biomarkers to assess
clinical effects, Immunology (Tregs), Pharmacokinetics

yidarmytom
26/1/2021
07:19
Trial completed: Topline data expected in
late January 2021

jostrummer
26/1/2021
07:06
I agree ABBYNAT, the more people who filter Rebel, ivan, munch etc the better, then we can get this board back to what it should be, discussing the investment case (good and bad) in a sensible polite manner, albeit with banter if warranted!
yidarmytom
Chat Pages: Latest  525  524  523  522  521  520  519  518  517  516  515  514  Older

Your Recent History

Delayed Upgrade Clock